In our previous studies, we showed that in a cohort of locally-advanced primary breast tumors treated with an anthracycline-based monotherapy, the methylation status of GSTP1 was positively associated with overall survival and independent of other known clinical and histopathological parameters [19]. The gene discussed is GSTP1; the disease is breast neoplasm.